nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—germ cell cancer—thyroid cancer	0.648	1	CtDrD
Ifosfamide—CYP3A7—Sorafenib—thyroid cancer	0.0284	0.142	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0284	0.142	CbGbCtD
Ifosfamide—CYP2B6—Sorafenib—thyroid cancer	0.027	0.135	CbGbCtD
Ifosfamide—CYP3A5—Sorafenib—thyroid cancer	0.0213	0.106	CbGbCtD
Ifosfamide—CYP2C8—Sorafenib—thyroid cancer	0.0205	0.102	CbGbCtD
Ifosfamide—CYP2C19—Sorafenib—thyroid cancer	0.0172	0.0856	CbGbCtD
Ifosfamide—CYP2B6—Doxorubicin—thyroid cancer	0.0164	0.0818	CbGbCtD
Ifosfamide—CYP2C9—Sorafenib—thyroid cancer	0.0143	0.0712	CbGbCtD
Ifosfamide—CYP3A4—Vandetanib—thyroid cancer	0.0138	0.0687	CbGbCtD
Ifosfamide—CYP3A4—Sorafenib—thyroid cancer	0.00831	0.0414	CbGbCtD
Ifosfamide—CYP3A4—Doxorubicin—thyroid cancer	0.00504	0.0251	CbGbCtD
Ifosfamide—PTGS1—Eicosanoid Synthesis—PTGES2—thyroid cancer	0.000511	0.117	CbGpPWpGaD
Ifosfamide—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGD—thyroid cancer	0.000384	0.0879	CbGpPWpGaD
Ifosfamide—PTGS1—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.000209	0.0478	CbGpPWpGaD
Ifosfamide—PTGS1—Arachidonic acid metabolism—HPGD—thyroid cancer	0.000139	0.0317	CbGpPWpGaD
Ifosfamide—CYP2B6—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000139	0.0317	CbGpPWpGaD
Ifosfamide—Inflammation—Doxorubicin—thyroid cancer	0.000136	0.000925	CcSEcCtD
Ifosfamide—Gait disturbance—Doxorubicin—thyroid cancer	0.000135	0.000919	CcSEcCtD
Ifosfamide—Nervous system disorder—Sorafenib—thyroid cancer	0.000135	0.000918	CcSEcCtD
Ifosfamide—Dizziness—Vandetanib—thyroid cancer	0.000135	0.000918	CcSEcCtD
Ifosfamide—Thrombocytopenia—Sorafenib—thyroid cancer	0.000135	0.000916	CcSEcCtD
Ifosfamide—Skin disorder—Sorafenib—thyroid cancer	0.000134	0.000909	CcSEcCtD
Ifosfamide—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.000132	0.000897	CcSEcCtD
Ifosfamide—Pulmonary embolism—Doxorubicin—thyroid cancer	0.000132	0.000897	CcSEcCtD
Ifosfamide—Anorexia—Sorafenib—thyroid cancer	0.000131	0.000892	CcSEcCtD
Ifosfamide—Coma—Epirubicin—thyroid cancer	0.00013	0.000886	CcSEcCtD
Ifosfamide—Vomiting—Vandetanib—thyroid cancer	0.00013	0.000882	CcSEcCtD
Ifosfamide—Neoplasm—Epirubicin—thyroid cancer	0.000129	0.000877	CcSEcCtD
Ifosfamide—Rash—Vandetanib—thyroid cancer	0.000129	0.000875	CcSEcCtD
Ifosfamide—Dermatitis—Vandetanib—thyroid cancer	0.000129	0.000874	CcSEcCtD
Ifosfamide—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.000128	0.000871	CcSEcCtD
Ifosfamide—Pulmonary oedema—Epirubicin—thyroid cancer	0.000127	0.000863	CcSEcCtD
Ifosfamide—Colitis—Doxorubicin—thyroid cancer	0.000127	0.000861	CcSEcCtD
Ifosfamide—Skin exfoliation—Doxorubicin—thyroid cancer	0.000126	0.000856	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000126	0.000853	CcSEcCtD
Ifosfamide—Sepsis—Epirubicin—thyroid cancer	0.000124	0.000841	CcSEcCtD
Ifosfamide—Dyspnoea—Sorafenib—thyroid cancer	0.000123	0.000834	CcSEcCtD
Ifosfamide—Nausea—Vandetanib—thyroid cancer	0.000121	0.000824	CcSEcCtD
Ifosfamide—Coma—Doxorubicin—thyroid cancer	0.000121	0.00082	CcSEcCtD
Ifosfamide—Phlebitis—Epirubicin—thyroid cancer	0.00012	0.000817	CcSEcCtD
Ifosfamide—Decreased appetite—Sorafenib—thyroid cancer	0.00012	0.000814	CcSEcCtD
Ifosfamide—Thrombophlebitis—Epirubicin—thyroid cancer	0.00012	0.000813	CcSEcCtD
Ifosfamide—Neoplasm—Doxorubicin—thyroid cancer	0.000119	0.000811	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000119	0.000808	CcSEcCtD
Ifosfamide—Fatigue—Sorafenib—thyroid cancer	0.000119	0.000807	CcSEcCtD
Ifosfamide—Hepatic function abnormal—Epirubicin—thyroid cancer	0.000119	0.000805	CcSEcCtD
Ifosfamide—Pain—Sorafenib—thyroid cancer	0.000118	0.0008	CcSEcCtD
Ifosfamide—Constipation—Sorafenib—thyroid cancer	0.000118	0.0008	CcSEcCtD
Ifosfamide—Pulmonary oedema—Doxorubicin—thyroid cancer	0.000118	0.000798	CcSEcCtD
Ifosfamide—Hepatic failure—Epirubicin—thyroid cancer	0.000115	0.000783	CcSEcCtD
Ifosfamide—Sepsis—Doxorubicin—thyroid cancer	0.000115	0.000778	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000113	0.000765	CcSEcCtD
Ifosfamide—Renal failure acute—Epirubicin—thyroid cancer	0.000112	0.000762	CcSEcCtD
Ifosfamide—Phlebitis—Doxorubicin—thyroid cancer	0.000111	0.000756	CcSEcCtD
Ifosfamide—Thrombophlebitis—Doxorubicin—thyroid cancer	0.000111	0.000752	CcSEcCtD
Ifosfamide—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00011	0.000745	CcSEcCtD
Ifosfamide—Urticaria—Sorafenib—thyroid cancer	0.000109	0.000744	CcSEcCtD
Ifosfamide—Body temperature increased—Sorafenib—thyroid cancer	0.000109	0.00074	CcSEcCtD
Ifosfamide—Abdominal pain—Sorafenib—thyroid cancer	0.000109	0.00074	CcSEcCtD
Ifosfamide—Renal impairment—Epirubicin—thyroid cancer	0.000109	0.000739	CcSEcCtD
Ifosfamide—Hepatic failure—Doxorubicin—thyroid cancer	0.000107	0.000725	CcSEcCtD
Ifosfamide—Cardiac failure—Epirubicin—thyroid cancer	0.000106	0.000721	CcSEcCtD
Ifosfamide—Renal failure acute—Doxorubicin—thyroid cancer	0.000104	0.000705	CcSEcCtD
Ifosfamide—Osteoarthritis—Epirubicin—thyroid cancer	0.000104	0.000704	CcSEcCtD
Ifosfamide—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000104	0.000704	CcSEcCtD
Ifosfamide—Pain in extremity—Epirubicin—thyroid cancer	0.000104	0.000704	CcSEcCtD
Ifosfamide—Hypersensitivity—Sorafenib—thyroid cancer	0.000101	0.00069	CcSEcCtD
Ifosfamide—Renal impairment—Doxorubicin—thyroid cancer	0.000101	0.000684	CcSEcCtD
Ifosfamide—Asthenia—Sorafenib—thyroid cancer	9.88e-05	0.000672	CcSEcCtD
Ifosfamide—Cardiac arrest—Epirubicin—thyroid cancer	9.85e-05	0.000669	CcSEcCtD
Ifosfamide—Cardiac failure—Doxorubicin—thyroid cancer	9.82e-05	0.000667	CcSEcCtD
Ifosfamide—CYP2C18—Metapathway biotransformation—CHST14—thyroid cancer	9.81e-05	0.0224	CbGpPWpGaD
Ifosfamide—Pruritus—Sorafenib—thyroid cancer	9.75e-05	0.000662	CcSEcCtD
Ifosfamide—Blood creatinine increased—Epirubicin—thyroid cancer	9.7e-05	0.000659	CcSEcCtD
Ifosfamide—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	9.58e-05	0.000651	CcSEcCtD
Ifosfamide—Pain in extremity—Doxorubicin—thyroid cancer	9.58e-05	0.000651	CcSEcCtD
Ifosfamide—Osteoarthritis—Doxorubicin—thyroid cancer	9.58e-05	0.000651	CcSEcCtD
Ifosfamide—Hypokalaemia—Epirubicin—thyroid cancer	9.43e-05	0.00064	CcSEcCtD
Ifosfamide—Diarrhoea—Sorafenib—thyroid cancer	9.43e-05	0.00064	CcSEcCtD
Ifosfamide—Breast disorder—Epirubicin—thyroid cancer	9.36e-05	0.000636	CcSEcCtD
Ifosfamide—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	9.33e-05	0.000634	CcSEcCtD
Ifosfamide—Cardiac arrest—Doxorubicin—thyroid cancer	9.11e-05	0.000619	CcSEcCtD
Ifosfamide—Dizziness—Sorafenib—thyroid cancer	9.11e-05	0.000619	CcSEcCtD
Ifosfamide—Blood creatinine increased—Doxorubicin—thyroid cancer	8.98e-05	0.00061	CcSEcCtD
Ifosfamide—CYP2C8—Arachidonic acid metabolism—HPGD—thyroid cancer	8.96e-05	0.0205	CbGpPWpGaD
Ifosfamide—Pancreatitis—Epirubicin—thyroid cancer	8.78e-05	0.000596	CcSEcCtD
Ifosfamide—Vomiting—Sorafenib—thyroid cancer	8.76e-05	0.000595	CcSEcCtD
Ifosfamide—Hypokalaemia—Doxorubicin—thyroid cancer	8.72e-05	0.000593	CcSEcCtD
Ifosfamide—Angina pectoris—Epirubicin—thyroid cancer	8.72e-05	0.000593	CcSEcCtD
Ifosfamide—Rash—Sorafenib—thyroid cancer	8.69e-05	0.00059	CcSEcCtD
Ifosfamide—Dermatitis—Sorafenib—thyroid cancer	8.68e-05	0.00059	CcSEcCtD
Ifosfamide—Breast disorder—Doxorubicin—thyroid cancer	8.66e-05	0.000588	CcSEcCtD
Ifosfamide—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	8.63e-05	0.000586	CcSEcCtD
Ifosfamide—Pancytopenia—Epirubicin—thyroid cancer	8.5e-05	0.000578	CcSEcCtD
Ifosfamide—Dysuria—Epirubicin—thyroid cancer	8.37e-05	0.000569	CcSEcCtD
Ifosfamide—Pollakiuria—Epirubicin—thyroid cancer	8.27e-05	0.000562	CcSEcCtD
Ifosfamide—Nausea—Sorafenib—thyroid cancer	8.18e-05	0.000556	CcSEcCtD
Ifosfamide—Pancreatitis—Doxorubicin—thyroid cancer	8.12e-05	0.000552	CcSEcCtD
Ifosfamide—Hyperglycaemia—Epirubicin—thyroid cancer	8.08e-05	0.000549	CcSEcCtD
Ifosfamide—Angina pectoris—Doxorubicin—thyroid cancer	8.07e-05	0.000548	CcSEcCtD
Ifosfamide—Pneumonia—Epirubicin—thyroid cancer	8.03e-05	0.000546	CcSEcCtD
Ifosfamide—CYP2C19—Arachidonic acid metabolism—HPGD—thyroid cancer	8e-05	0.0183	CbGpPWpGaD
Ifosfamide—Infestation NOS—Epirubicin—thyroid cancer	7.98e-05	0.000542	CcSEcCtD
Ifosfamide—Infestation—Epirubicin—thyroid cancer	7.98e-05	0.000542	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	7.91e-05	0.000538	CcSEcCtD
Ifosfamide—Pancytopenia—Doxorubicin—thyroid cancer	7.87e-05	0.000534	CcSEcCtD
Ifosfamide—Renal failure—Epirubicin—thyroid cancer	7.85e-05	0.000533	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Epirubicin—thyroid cancer	7.82e-05	0.000532	CcSEcCtD
Ifosfamide—Stomatitis—Epirubicin—thyroid cancer	7.78e-05	0.000529	CcSEcCtD
Ifosfamide—Conjunctivitis—Epirubicin—thyroid cancer	7.76e-05	0.000527	CcSEcCtD
Ifosfamide—Dysuria—Doxorubicin—thyroid cancer	7.75e-05	0.000526	CcSEcCtD
Ifosfamide—Pollakiuria—Doxorubicin—thyroid cancer	7.65e-05	0.00052	CcSEcCtD
Ifosfamide—Haematuria—Epirubicin—thyroid cancer	7.61e-05	0.000517	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Epirubicin—thyroid cancer	7.55e-05	0.000513	CcSEcCtD
Ifosfamide—Hyperglycaemia—Doxorubicin—thyroid cancer	7.47e-05	0.000508	CcSEcCtD
Ifosfamide—Agranulocytosis—Epirubicin—thyroid cancer	7.45e-05	0.000506	CcSEcCtD
Ifosfamide—Pneumonia—Doxorubicin—thyroid cancer	7.43e-05	0.000505	CcSEcCtD
Ifosfamide—Infestation NOS—Doxorubicin—thyroid cancer	7.39e-05	0.000502	CcSEcCtD
Ifosfamide—Infestation—Doxorubicin—thyroid cancer	7.39e-05	0.000502	CcSEcCtD
Ifosfamide—CYP2A6—Fluoropyrimidine Activity—SMUG1—thyroid cancer	7.36e-05	0.0168	CbGpPWpGaD
Ifosfamide—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	7.32e-05	0.000498	CcSEcCtD
Ifosfamide—Bradycardia—Epirubicin—thyroid cancer	7.3e-05	0.000496	CcSEcCtD
Ifosfamide—CYP2C9—Arachidonic acid metabolism—HPGD—thyroid cancer	7.3e-05	0.0167	CbGpPWpGaD
Ifosfamide—Renal failure—Doxorubicin—thyroid cancer	7.26e-05	0.000493	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Doxorubicin—thyroid cancer	7.24e-05	0.000492	CcSEcCtD
Ifosfamide—Haemoglobin—Epirubicin—thyroid cancer	7.2e-05	0.000489	CcSEcCtD
Ifosfamide—Stomatitis—Doxorubicin—thyroid cancer	7.2e-05	0.000489	CcSEcCtD
Ifosfamide—Conjunctivitis—Doxorubicin—thyroid cancer	7.18e-05	0.000488	CcSEcCtD
Ifosfamide—Hepatitis—Epirubicin—thyroid cancer	7.17e-05	0.000487	CcSEcCtD
Ifosfamide—Haemorrhage—Epirubicin—thyroid cancer	7.17e-05	0.000487	CcSEcCtD
Ifosfamide—Urinary tract disorder—Epirubicin—thyroid cancer	7.08e-05	0.000481	CcSEcCtD
Ifosfamide—Haematuria—Doxorubicin—thyroid cancer	7.04e-05	0.000478	CcSEcCtD
Ifosfamide—Connective tissue disorder—Epirubicin—thyroid cancer	7.04e-05	0.000478	CcSEcCtD
Ifosfamide—Urethral disorder—Epirubicin—thyroid cancer	7.02e-05	0.000477	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Doxorubicin—thyroid cancer	6.99e-05	0.000475	CcSEcCtD
Ifosfamide—Visual impairment—Epirubicin—thyroid cancer	6.91e-05	0.000469	CcSEcCtD
Ifosfamide—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—thyroid cancer	6.89e-05	0.0158	CbGpPWpGaD
Ifosfamide—Agranulocytosis—Doxorubicin—thyroid cancer	6.89e-05	0.000468	CcSEcCtD
Ifosfamide—Erythema multiforme—Epirubicin—thyroid cancer	6.78e-05	0.00046	CcSEcCtD
Ifosfamide—CYP2A6—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	6.77e-05	0.0155	CbGpPWpGaD
Ifosfamide—Bradycardia—Doxorubicin—thyroid cancer	6.75e-05	0.000459	CcSEcCtD
Ifosfamide—CYP2C18—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	6.72e-05	0.0154	CbGpPWpGaD
Ifosfamide—Eye disorder—Epirubicin—thyroid cancer	6.7e-05	0.000455	CcSEcCtD
Ifosfamide—Tinnitus—Epirubicin—thyroid cancer	6.68e-05	0.000454	CcSEcCtD
Ifosfamide—Haemoglobin—Doxorubicin—thyroid cancer	6.66e-05	0.000453	CcSEcCtD
Ifosfamide—Cardiac disorder—Epirubicin—thyroid cancer	6.65e-05	0.000452	CcSEcCtD
Ifosfamide—Flushing—Epirubicin—thyroid cancer	6.65e-05	0.000452	CcSEcCtD
Ifosfamide—Haemorrhage—Doxorubicin—thyroid cancer	6.63e-05	0.00045	CcSEcCtD
Ifosfamide—Hepatitis—Doxorubicin—thyroid cancer	6.63e-05	0.00045	CcSEcCtD
Ifosfamide—Urinary tract disorder—Doxorubicin—thyroid cancer	6.55e-05	0.000445	CcSEcCtD
Ifosfamide—CYP3A7—Metapathway biotransformation—CHST14—thyroid cancer	6.52e-05	0.0149	CbGpPWpGaD
Ifosfamide—Connective tissue disorder—Doxorubicin—thyroid cancer	6.52e-05	0.000443	CcSEcCtD
Ifosfamide—Angiopathy—Epirubicin—thyroid cancer	6.5e-05	0.000442	CcSEcCtD
Ifosfamide—Urethral disorder—Doxorubicin—thyroid cancer	6.5e-05	0.000442	CcSEcCtD
Ifosfamide—Immune system disorder—Epirubicin—thyroid cancer	6.47e-05	0.00044	CcSEcCtD
Ifosfamide—Mediastinal disorder—Epirubicin—thyroid cancer	6.46e-05	0.000439	CcSEcCtD
Ifosfamide—Chills—Epirubicin—thyroid cancer	6.43e-05	0.000437	CcSEcCtD
Ifosfamide—Arrhythmia—Epirubicin—thyroid cancer	6.4e-05	0.000435	CcSEcCtD
Ifosfamide—Visual impairment—Doxorubicin—thyroid cancer	6.39e-05	0.000434	CcSEcCtD
Ifosfamide—Alopecia—Epirubicin—thyroid cancer	6.33e-05	0.00043	CcSEcCtD
Ifosfamide—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	6.3e-05	0.0144	CbGpPWpGaD
Ifosfamide—Mental disorder—Epirubicin—thyroid cancer	6.28e-05	0.000427	CcSEcCtD
Ifosfamide—Erythema multiforme—Doxorubicin—thyroid cancer	6.27e-05	0.000426	CcSEcCtD
Ifosfamide—Erythema—Epirubicin—thyroid cancer	6.24e-05	0.000424	CcSEcCtD
Ifosfamide—Malnutrition—Epirubicin—thyroid cancer	6.24e-05	0.000424	CcSEcCtD
Ifosfamide—Eye disorder—Doxorubicin—thyroid cancer	6.2e-05	0.000421	CcSEcCtD
Ifosfamide—Tinnitus—Doxorubicin—thyroid cancer	6.18e-05	0.00042	CcSEcCtD
Ifosfamide—Flushing—Doxorubicin—thyroid cancer	6.15e-05	0.000418	CcSEcCtD
Ifosfamide—Cardiac disorder—Doxorubicin—thyroid cancer	6.15e-05	0.000418	CcSEcCtD
Ifosfamide—Angiopathy—Doxorubicin—thyroid cancer	6.02e-05	0.000409	CcSEcCtD
Ifosfamide—Immune system disorder—Doxorubicin—thyroid cancer	5.99e-05	0.000407	CcSEcCtD
Ifosfamide—Mediastinal disorder—Doxorubicin—thyroid cancer	5.98e-05	0.000406	CcSEcCtD
Ifosfamide—Chills—Doxorubicin—thyroid cancer	5.95e-05	0.000404	CcSEcCtD
Ifosfamide—Arrhythmia—Doxorubicin—thyroid cancer	5.92e-05	0.000402	CcSEcCtD
Ifosfamide—Vision blurred—Epirubicin—thyroid cancer	5.88e-05	0.000399	CcSEcCtD
Ifosfamide—Alopecia—Doxorubicin—thyroid cancer	5.86e-05	0.000398	CcSEcCtD
Ifosfamide—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—thyroid cancer	5.86e-05	0.0134	CbGpPWpGaD
Ifosfamide—Mental disorder—Doxorubicin—thyroid cancer	5.81e-05	0.000395	CcSEcCtD
Ifosfamide—Ill-defined disorder—Epirubicin—thyroid cancer	5.79e-05	0.000393	CcSEcCtD
Ifosfamide—Erythema—Doxorubicin—thyroid cancer	5.77e-05	0.000392	CcSEcCtD
Ifosfamide—Malnutrition—Doxorubicin—thyroid cancer	5.77e-05	0.000392	CcSEcCtD
Ifosfamide—Anaemia—Epirubicin—thyroid cancer	5.77e-05	0.000392	CcSEcCtD
Ifosfamide—Agitation—Epirubicin—thyroid cancer	5.73e-05	0.000389	CcSEcCtD
Ifosfamide—Malaise—Epirubicin—thyroid cancer	5.63e-05	0.000382	CcSEcCtD
Ifosfamide—Vertigo—Epirubicin—thyroid cancer	5.6e-05	0.000381	CcSEcCtD
Ifosfamide—Leukopenia—Epirubicin—thyroid cancer	5.58e-05	0.000379	CcSEcCtD
Ifosfamide—Palpitations—Epirubicin—thyroid cancer	5.51e-05	0.000375	CcSEcCtD
Ifosfamide—CYP2B6—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	5.47e-05	0.0125	CbGpPWpGaD
Ifosfamide—CYP2C18—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	5.45e-05	0.0125	CbGpPWpGaD
Ifosfamide—Cough—Epirubicin—thyroid cancer	5.44e-05	0.00037	CcSEcCtD
Ifosfamide—Vision blurred—Doxorubicin—thyroid cancer	5.44e-05	0.00037	CcSEcCtD
Ifosfamide—Convulsion—Epirubicin—thyroid cancer	5.4e-05	0.000367	CcSEcCtD
Ifosfamide—PTGS1—Overview of nanoparticle effects—PTGS2—thyroid cancer	5.4e-05	0.0123	CbGpPWpGaD
Ifosfamide—Hypertension—Epirubicin—thyroid cancer	5.39e-05	0.000366	CcSEcCtD
Ifosfamide—Ill-defined disorder—Doxorubicin—thyroid cancer	5.36e-05	0.000364	CcSEcCtD
Ifosfamide—CYP3A5—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	5.34e-05	0.0122	CbGpPWpGaD
Ifosfamide—Anaemia—Doxorubicin—thyroid cancer	5.33e-05	0.000362	CcSEcCtD
Ifosfamide—Arthralgia—Epirubicin—thyroid cancer	5.31e-05	0.000361	CcSEcCtD
Ifosfamide—Chest pain—Epirubicin—thyroid cancer	5.31e-05	0.000361	CcSEcCtD
Ifosfamide—Myalgia—Epirubicin—thyroid cancer	5.31e-05	0.000361	CcSEcCtD
Ifosfamide—Agitation—Doxorubicin—thyroid cancer	5.3e-05	0.00036	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	5.27e-05	0.000358	CcSEcCtD
Ifosfamide—Discomfort—Epirubicin—thyroid cancer	5.25e-05	0.000357	CcSEcCtD
Ifosfamide—Malaise—Doxorubicin—thyroid cancer	5.21e-05	0.000354	CcSEcCtD
Ifosfamide—Vertigo—Doxorubicin—thyroid cancer	5.19e-05	0.000352	CcSEcCtD
Ifosfamide—Leukopenia—Doxorubicin—thyroid cancer	5.17e-05	0.000351	CcSEcCtD
Ifosfamide—Confusional state—Epirubicin—thyroid cancer	5.13e-05	0.000349	CcSEcCtD
Ifosfamide—Palpitations—Doxorubicin—thyroid cancer	5.1e-05	0.000347	CcSEcCtD
Ifosfamide—Anaphylactic shock—Epirubicin—thyroid cancer	5.09e-05	0.000346	CcSEcCtD
Ifosfamide—Oedema—Epirubicin—thyroid cancer	5.09e-05	0.000346	CcSEcCtD
Ifosfamide—Infection—Epirubicin—thyroid cancer	5.06e-05	0.000344	CcSEcCtD
Ifosfamide—Cough—Doxorubicin—thyroid cancer	5.04e-05	0.000342	CcSEcCtD
Ifosfamide—Convulsion—Doxorubicin—thyroid cancer	5e-05	0.00034	CcSEcCtD
Ifosfamide—Nervous system disorder—Epirubicin—thyroid cancer	4.99e-05	0.000339	CcSEcCtD
Ifosfamide—Thrombocytopenia—Epirubicin—thyroid cancer	4.98e-05	0.000339	CcSEcCtD
Ifosfamide—Hypertension—Doxorubicin—thyroid cancer	4.98e-05	0.000339	CcSEcCtD
Ifosfamide—Skin disorder—Epirubicin—thyroid cancer	4.95e-05	0.000336	CcSEcCtD
Ifosfamide—Hyperhidrosis—Epirubicin—thyroid cancer	4.92e-05	0.000334	CcSEcCtD
Ifosfamide—Myalgia—Doxorubicin—thyroid cancer	4.91e-05	0.000334	CcSEcCtD
Ifosfamide—Chest pain—Doxorubicin—thyroid cancer	4.91e-05	0.000334	CcSEcCtD
Ifosfamide—Arthralgia—Doxorubicin—thyroid cancer	4.91e-05	0.000334	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	4.88e-05	0.000332	CcSEcCtD
Ifosfamide—Discomfort—Doxorubicin—thyroid cancer	4.86e-05	0.00033	CcSEcCtD
Ifosfamide—Anorexia—Epirubicin—thyroid cancer	4.85e-05	0.00033	CcSEcCtD
Ifosfamide—CYP2B6—Metapathway biotransformation—CHST14—thyroid cancer	4.82e-05	0.011	CbGpPWpGaD
Ifosfamide—Hypotension—Epirubicin—thyroid cancer	4.76e-05	0.000323	CcSEcCtD
Ifosfamide—Confusional state—Doxorubicin—thyroid cancer	4.75e-05	0.000323	CcSEcCtD
Ifosfamide—CYP3A5—Metapathway biotransformation—CHST14—thyroid cancer	4.71e-05	0.0108	CbGpPWpGaD
Ifosfamide—Oedema—Doxorubicin—thyroid cancer	4.71e-05	0.00032	CcSEcCtD
Ifosfamide—Anaphylactic shock—Doxorubicin—thyroid cancer	4.71e-05	0.00032	CcSEcCtD
Ifosfamide—Infection—Doxorubicin—thyroid cancer	4.68e-05	0.000318	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Epirubicin—thyroid cancer	4.64e-05	0.000315	CcSEcCtD
Ifosfamide—Nervous system disorder—Doxorubicin—thyroid cancer	4.62e-05	0.000314	CcSEcCtD
Ifosfamide—Thrombocytopenia—Doxorubicin—thyroid cancer	4.61e-05	0.000313	CcSEcCtD
Ifosfamide—Skin disorder—Doxorubicin—thyroid cancer	4.58e-05	0.000311	CcSEcCtD
Ifosfamide—Paraesthesia—Epirubicin—thyroid cancer	4.57e-05	0.000311	CcSEcCtD
Ifosfamide—Hyperhidrosis—Doxorubicin—thyroid cancer	4.55e-05	0.000309	CcSEcCtD
Ifosfamide—Dyspnoea—Epirubicin—thyroid cancer	4.54e-05	0.000308	CcSEcCtD
Ifosfamide—Somnolence—Epirubicin—thyroid cancer	4.53e-05	0.000308	CcSEcCtD
Ifosfamide—Anorexia—Doxorubicin—thyroid cancer	4.49e-05	0.000305	CcSEcCtD
Ifosfamide—PTGS1—Eicosanoid Synthesis—PTGS2—thyroid cancer	4.48e-05	0.0102	CbGpPWpGaD
Ifosfamide—CYP3A7—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	4.47e-05	0.0102	CbGpPWpGaD
Ifosfamide—Decreased appetite—Epirubicin—thyroid cancer	4.43e-05	0.000301	CcSEcCtD
Ifosfamide—Hypotension—Doxorubicin—thyroid cancer	4.4e-05	0.000299	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Epirubicin—thyroid cancer	4.4e-05	0.000299	CcSEcCtD
Ifosfamide—Fatigue—Epirubicin—thyroid cancer	4.39e-05	0.000298	CcSEcCtD
Ifosfamide—Pain—Epirubicin—thyroid cancer	4.35e-05	0.000296	CcSEcCtD
Ifosfamide—Constipation—Epirubicin—thyroid cancer	4.35e-05	0.000296	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	4.29e-05	0.000292	CcSEcCtD
Ifosfamide—Paraesthesia—Doxorubicin—thyroid cancer	4.23e-05	0.000287	CcSEcCtD
Ifosfamide—Dyspnoea—Doxorubicin—thyroid cancer	4.2e-05	0.000285	CcSEcCtD
Ifosfamide—Feeling abnormal—Epirubicin—thyroid cancer	4.2e-05	0.000285	CcSEcCtD
Ifosfamide—Somnolence—Doxorubicin—thyroid cancer	4.19e-05	0.000285	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Epirubicin—thyroid cancer	4.16e-05	0.000283	CcSEcCtD
Ifosfamide—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	4.13e-05	0.00945	CbGpPWpGaD
Ifosfamide—CYP2A6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	4.1e-05	0.00937	CbGpPWpGaD
Ifosfamide—Decreased appetite—Doxorubicin—thyroid cancer	4.1e-05	0.000278	CcSEcCtD
Ifosfamide—CYP2C8—Metapathway biotransformation—CHST14—thyroid cancer	4.08e-05	0.00933	CbGpPWpGaD
Ifosfamide—Gastrointestinal disorder—Doxorubicin—thyroid cancer	4.07e-05	0.000276	CcSEcCtD
Ifosfamide—Fatigue—Doxorubicin—thyroid cancer	4.06e-05	0.000276	CcSEcCtD
Ifosfamide—Urticaria—Epirubicin—thyroid cancer	4.04e-05	0.000275	CcSEcCtD
Ifosfamide—Constipation—Doxorubicin—thyroid cancer	4.03e-05	0.000274	CcSEcCtD
Ifosfamide—Pain—Doxorubicin—thyroid cancer	4.03e-05	0.000274	CcSEcCtD
Ifosfamide—Abdominal pain—Epirubicin—thyroid cancer	4.02e-05	0.000273	CcSEcCtD
Ifosfamide—Body temperature increased—Epirubicin—thyroid cancer	4.02e-05	0.000273	CcSEcCtD
Ifosfamide—Feeling abnormal—Doxorubicin—thyroid cancer	3.88e-05	0.000264	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Doxorubicin—thyroid cancer	3.85e-05	0.000262	CcSEcCtD
Ifosfamide—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	3.77e-05	0.00862	CbGpPWpGaD
Ifosfamide—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	3.77e-05	0.00861	CbGpPWpGaD
Ifosfamide—Hypersensitivity—Epirubicin—thyroid cancer	3.75e-05	0.000255	CcSEcCtD
Ifosfamide—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—thyroid cancer	3.75e-05	0.00857	CbGpPWpGaD
Ifosfamide—Urticaria—Doxorubicin—thyroid cancer	3.74e-05	0.000254	CcSEcCtD
Ifosfamide—Abdominal pain—Doxorubicin—thyroid cancer	3.72e-05	0.000253	CcSEcCtD
Ifosfamide—Body temperature increased—Doxorubicin—thyroid cancer	3.72e-05	0.000253	CcSEcCtD
Ifosfamide—Asthenia—Epirubicin—thyroid cancer	3.65e-05	0.000248	CcSEcCtD
Ifosfamide—CYP2C19—Metapathway biotransformation—CHST14—thyroid cancer	3.64e-05	0.00833	CbGpPWpGaD
Ifosfamide—CYP3A7—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	3.62e-05	0.00829	CbGpPWpGaD
Ifosfamide—Pruritus—Epirubicin—thyroid cancer	3.6e-05	0.000245	CcSEcCtD
Ifosfamide—PTGS1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	3.51e-05	0.00803	CbGpPWpGaD
Ifosfamide—Diarrhoea—Epirubicin—thyroid cancer	3.48e-05	0.000237	CcSEcCtD
Ifosfamide—Hypersensitivity—Doxorubicin—thyroid cancer	3.47e-05	0.000236	CcSEcCtD
Ifosfamide—Asthenia—Doxorubicin—thyroid cancer	3.38e-05	0.00023	CcSEcCtD
Ifosfamide—Dizziness—Epirubicin—thyroid cancer	3.37e-05	0.000229	CcSEcCtD
Ifosfamide—Pruritus—Doxorubicin—thyroid cancer	3.33e-05	0.000226	CcSEcCtD
Ifosfamide—CYP2C9—Metapathway biotransformation—CHST14—thyroid cancer	3.32e-05	0.0076	CbGpPWpGaD
Ifosfamide—CYP2A6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	3.32e-05	0.0076	CbGpPWpGaD
Ifosfamide—CYP2B6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	3.31e-05	0.00756	CbGpPWpGaD
Ifosfamide—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	3.29e-05	0.00752	CbGpPWpGaD
Ifosfamide—Vomiting—Epirubicin—thyroid cancer	3.24e-05	0.00022	CcSEcCtD
Ifosfamide—CYP3A5—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	3.23e-05	0.00739	CbGpPWpGaD
Ifosfamide—Diarrhoea—Doxorubicin—thyroid cancer	3.22e-05	0.000219	CcSEcCtD
Ifosfamide—Rash—Epirubicin—thyroid cancer	3.21e-05	0.000218	CcSEcCtD
Ifosfamide—Dermatitis—Epirubicin—thyroid cancer	3.21e-05	0.000218	CcSEcCtD
Ifosfamide—Dizziness—Doxorubicin—thyroid cancer	3.12e-05	0.000212	CcSEcCtD
Ifosfamide—Nausea—Epirubicin—thyroid cancer	3.02e-05	0.000205	CcSEcCtD
Ifosfamide—Vomiting—Doxorubicin—thyroid cancer	3e-05	0.000203	CcSEcCtD
Ifosfamide—Rash—Doxorubicin—thyroid cancer	2.97e-05	0.000202	CcSEcCtD
Ifosfamide—Dermatitis—Doxorubicin—thyroid cancer	2.97e-05	0.000202	CcSEcCtD
Ifosfamide—CYP2C18—Biological oxidations—RXRA—thyroid cancer	2.9e-05	0.00662	CbGpPWpGaD
Ifosfamide—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	2.8e-05	0.0064	CbGpPWpGaD
Ifosfamide—Nausea—Doxorubicin—thyroid cancer	2.8e-05	0.00019	CcSEcCtD
Ifosfamide—CYP2B6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	2.68e-05	0.00613	CbGpPWpGaD
Ifosfamide—CYP3A5—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	2.62e-05	0.00599	CbGpPWpGaD
Ifosfamide—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	2.5e-05	0.00571	CbGpPWpGaD
Ifosfamide—PTGS1—Arachidonic acid metabolism—PTGS2—thyroid cancer	2.49e-05	0.00569	CbGpPWpGaD
Ifosfamide—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	2.48e-05	0.00568	CbGpPWpGaD
Ifosfamide—CYP2A6—NRF2 pathway—SLC5A5—thyroid cancer	2.39e-05	0.00547	CbGpPWpGaD
Ifosfamide—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	2.28e-05	0.00521	CbGpPWpGaD
Ifosfamide—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	2.27e-05	0.00519	CbGpPWpGaD
Ifosfamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	2.27e-05	0.00518	CbGpPWpGaD
Ifosfamide—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	2.19e-05	0.00501	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—MINPP1—thyroid cancer	2.13e-05	0.00486	CbGpPWpGaD
Ifosfamide—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	2.03e-05	0.00463	CbGpPWpGaD
Ifosfamide—CYP2A6—NRF2 pathway—RXRA—thyroid cancer	2.01e-05	0.0046	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	1.98e-05	0.00454	CbGpPWpGaD
Ifosfamide—CYP2A6—Fluoropyrimidine Activity—TP53—thyroid cancer	1.95e-05	0.00447	CbGpPWpGaD
Ifosfamide—CYP3A7—Biological oxidations—RXRA—thyroid cancer	1.92e-05	0.0044	CbGpPWpGaD
Ifosfamide—PTGS1—Biological oxidations—RXRA—thyroid cancer	1.87e-05	0.00427	CbGpPWpGaD
Ifosfamide—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	1.85e-05	0.00422	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—NDUFA13—thyroid cancer	1.81e-05	0.00414	CbGpPWpGaD
Ifosfamide—CYP2A6—Biological oxidations—RXRA—thyroid cancer	1.76e-05	0.00403	CbGpPWpGaD
Ifosfamide—CYP2A6—NRF2 pathway—NRG1—thyroid cancer	1.74e-05	0.00398	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—CHST14—thyroid cancer	1.7e-05	0.00389	CbGpPWpGaD
Ifosfamide—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	1.61e-05	0.00368	CbGpPWpGaD
Ifosfamide—PTGS1—Selenium Micronutrient Network—PTGS2—thyroid cancer	1.58e-05	0.00362	CbGpPWpGaD
Ifosfamide—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	1.5e-05	0.00344	CbGpPWpGaD
Ifosfamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	1.49e-05	0.00342	CbGpPWpGaD
Ifosfamide—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	1.44e-05	0.00328	CbGpPWpGaD
Ifosfamide—CYP2B6—Biological oxidations—RXRA—thyroid cancer	1.42e-05	0.00326	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—MINPP1—thyroid cancer	1.41e-05	0.00323	CbGpPWpGaD
Ifosfamide—CYP3A5—Biological oxidations—RXRA—thyroid cancer	1.39e-05	0.00318	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—MINPP1—thyroid cancer	1.37e-05	0.00313	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—HPGD—thyroid cancer	1.37e-05	0.00313	CbGpPWpGaD
Ifosfamide—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	1.31e-05	0.00299	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—MINPP1—thyroid cancer	1.3e-05	0.00296	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	1.28e-05	0.00293	CbGpPWpGaD
Ifosfamide—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	1.22e-05	0.00278	CbGpPWpGaD
Ifosfamide—CYP2C8—Biological oxidations—RXRA—thyroid cancer	1.21e-05	0.00276	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—NDUFA13—thyroid cancer	1.2e-05	0.00275	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—NDUFA13—thyroid cancer	1.17e-05	0.00267	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	1.14e-05	0.00261	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CHST14—thyroid cancer	1.13e-05	0.00259	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—NDUFA13—thyroid cancer	1.1e-05	0.00252	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CHST14—thyroid cancer	1.1e-05	0.00251	CbGpPWpGaD
Ifosfamide—CYP2C19—Biological oxidations—RXRA—thyroid cancer	1.08e-05	0.00246	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—MINPP1—thyroid cancer	1.05e-05	0.00239	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	1.04e-05	0.00238	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CHST14—thyroid cancer	1.04e-05	0.00237	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—MINPP1—thyroid cancer	1.02e-05	0.00234	CbGpPWpGaD
Ifosfamide—CYP2C9—Biological oxidations—RXRA—thyroid cancer	9.81e-06	0.00224	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—HPGD—thyroid cancer	9.11e-06	0.00208	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—NDUFA13—thyroid cancer	8.89e-06	0.00203	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—MINPP1—thyroid cancer	8.85e-06	0.00202	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—HPGD—thyroid cancer	8.83e-06	0.00202	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—NDUFA13—thyroid cancer	8.69e-06	0.00199	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CHST14—thyroid cancer	8.36e-06	0.00191	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—HPGD—thyroid cancer	8.35e-06	0.00191	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CHST14—thyroid cancer	8.17e-06	0.00187	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—MINPP1—thyroid cancer	7.9e-06	0.00181	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—TPR—thyroid cancer	7.87e-06	0.0018	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PRKAR1A—thyroid cancer	7.74e-06	0.00177	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—NDUFA13—thyroid cancer	7.53e-06	0.00172	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—MINPP1—thyroid cancer	7.21e-06	0.00165	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.16e-06	0.00164	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CHST14—thyroid cancer	7.08e-06	0.00162	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—HPGD—thyroid cancer	6.74e-06	0.00154	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—NDUFA13—thyroid cancer	6.72e-06	0.00154	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—HPGD—thyroid cancer	6.59e-06	0.00151	CbGpPWpGaD
Ifosfamide—CYP3A4—Biological oxidations—RXRA—thyroid cancer	6.47e-06	0.00148	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CHST14—thyroid cancer	6.32e-06	0.00144	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—NDUFA13—thyroid cancer	6.13e-06	0.0014	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—SLC5A5—thyroid cancer	5.89e-06	0.00135	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CHST14—thyroid cancer	5.76e-06	0.00132	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—HPGD—thyroid cancer	5.71e-06	0.0013	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—TPR—thyroid cancer	5.23e-06	0.0012	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	5.15e-06	0.00118	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—HPGD—thyroid cancer	5.09e-06	0.00116	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—TPR—thyroid cancer	5.07e-06	0.00116	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PRKAR1A—thyroid cancer	4.99e-06	0.00114	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—RXRA—thyroid cancer	4.95e-06	0.00113	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—TPR—thyroid cancer	4.8e-06	0.0011	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—MINPP1—thyroid cancer	4.75e-06	0.00109	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PRKAR1A—thyroid cancer	4.72e-06	0.00108	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—HPGD—thyroid cancer	4.64e-06	0.00106	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.63e-06	0.00106	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.52e-06	0.00103	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.13e-06	0.000945	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NDUFA13—thyroid cancer	4.04e-06	0.000924	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—SLC5A5—thyroid cancer	3.92e-06	0.000896	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—TPR—thyroid cancer	3.87e-06	0.000885	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	3.81e-06	0.000871	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CHST14—thyroid cancer	3.8e-06	0.000869	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—SLC5A5—thyroid cancer	3.8e-06	0.000868	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—TPR—thyroid cancer	3.78e-06	0.000865	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.77e-06	0.000861	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	3.72e-06	0.000851	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—SLC5A5—thyroid cancer	3.59e-06	0.000821	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.56e-06	0.000814	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—RXRA—thyroid cancer	3.29e-06	0.000753	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—TPR—thyroid cancer	3.28e-06	0.000749	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	3.22e-06	0.000737	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—RXRA—thyroid cancer	3.19e-06	0.00073	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PPARG—thyroid cancer	3.13e-06	0.000715	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.1e-06	0.00071	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—HPGD—thyroid cancer	3.06e-06	0.0007	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—RXRA—thyroid cancer	3.02e-06	0.00069	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—TPR—thyroid cancer	2.92e-06	0.000669	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.92e-06	0.000668	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—SLC5A5—thyroid cancer	2.9e-06	0.000663	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	2.88e-06	0.000658	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—SLC5A5—thyroid cancer	2.83e-06	0.000648	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—TPR—thyroid cancer	2.67e-06	0.00061	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	2.62e-06	0.0006	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.61e-06	0.000596	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PTGS2—thyroid cancer	2.46e-06	0.000562	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—SLC5A5—thyroid cancer	2.45e-06	0.000561	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—RXRA—thyroid cancer	2.43e-06	0.000557	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—RXRA—thyroid cancer	2.38e-06	0.000544	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.38e-06	0.000544	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.3e-06	0.000526	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—SLC5A5—thyroid cancer	2.19e-06	0.000501	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PTEN—thyroid cancer	2.14e-06	0.00049	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PPARG—thyroid cancer	2.08e-06	0.000475	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—RXRA—thyroid cancer	2.06e-06	0.000471	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.05e-06	0.000469	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PPARG—thyroid cancer	2.01e-06	0.000461	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2e-06	0.000458	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—SLC5A5—thyroid cancer	2e-06	0.000457	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PPARG—thyroid cancer	1.9e-06	0.000436	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.87e-06	0.000428	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—RXRA—thyroid cancer	1.84e-06	0.000421	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.79e-06	0.000409	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—TPR—thyroid cancer	1.76e-06	0.000402	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.73e-06	0.000396	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—RXRA—thyroid cancer	1.68e-06	0.000384	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PTGS2—thyroid cancer	1.63e-06	0.000374	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.63e-06	0.000373	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PTGS2—thyroid cancer	1.58e-06	0.000362	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PPARG—thyroid cancer	1.54e-06	0.000351	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PPARG—thyroid cancer	1.5e-06	0.000344	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PTGS2—thyroid cancer	1.5e-06	0.000343	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PTEN—thyroid cancer	1.43e-06	0.000326	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PTEN—thyroid cancer	1.38e-06	0.000316	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.32e-06	0.000301	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PTEN—thyroid cancer	1.31e-06	0.000299	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PPARG—thyroid cancer	1.3e-06	0.000298	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—AKT1—thyroid cancer	1.24e-06	0.000283	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PTGS2—thyroid cancer	1.21e-06	0.000277	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PTGS2—thyroid cancer	1.18e-06	0.00027	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PPARG—thyroid cancer	1.16e-06	0.000266	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—RXRA—thyroid cancer	1.11e-06	0.000253	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PPARG—thyroid cancer	1.06e-06	0.000242	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PTEN—thyroid cancer	1.05e-06	0.000241	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PTEN—thyroid cancer	1.03e-06	0.000236	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PTGS2—thyroid cancer	1.02e-06	0.000234	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PTGS2—thyroid cancer	9.14e-07	0.000209	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PTEN—thyroid cancer	8.93e-07	0.000204	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PTGS2—thyroid cancer	8.33e-07	0.000191	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—AKT1—thyroid cancer	8.22e-07	0.000188	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PTEN—thyroid cancer	7.97e-07	0.000182	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—AKT1—thyroid cancer	7.96e-07	0.000182	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—AKT1—thyroid cancer	7.53e-07	0.000172	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PTEN—thyroid cancer	7.27e-07	0.000166	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PPARG—thyroid cancer	6.98e-07	0.00016	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—AKT1—thyroid cancer	6.08e-07	0.000139	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—AKT1—thyroid cancer	5.94e-07	0.000136	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PTGS2—thyroid cancer	5.49e-07	0.000126	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—AKT1—thyroid cancer	5.14e-07	0.000118	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PTEN—thyroid cancer	4.79e-07	0.00011	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—AKT1—thyroid cancer	4.59e-07	0.000105	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—AKT1—thyroid cancer	4.19e-07	9.58e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—AKT1—thyroid cancer	2.76e-07	6.32e-05	CbGpPWpGaD
